HKG:0460 Revenue

In the year 2025, Sihuan Pharmaceutical Holdings Group had annual revenue of 2.62B CNY with 37.71% growth. Sihuan Pharmaceutical Holdings Group had revenue of 1.47B in the half year ending December 31, 2025, with 82.87% growth.

Revenue

2.62B CNY

Revenue Growth

+37.71%

P/S Ratio

4.13

Revenue / Employee

920.86K CNY

Employees

2,843

Market Cap

12.03B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.62B	716.90M	37.71%
Dec 31, 2024	1.90B	40.57M	2.18%
Dec 31, 2023	1.86B	-320.65M	-14.70%
Dec 31, 2022	2.18B	-857.20M	-28.21%
Dec 31, 2021	3.04B	574.17M	23.30%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
China Traditional Chinese Medicine Holdings Co.	16.41B
The United Laboratories International Holdings	14.70B
Shandong Xinhua Pharmaceutical Company	9.74B
Luye Pharma Group	7.02B
SSY Group	4.17B
Consun Pharmaceutical Group	3.80B
China Shineway Pharmaceutical Group	3.49B
CanSino Biologics	1.19B

Revenue Rankings

Sihuan Pharmaceutical Holdings Group News

3 years ago - Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA - PRNewsWire

More News